Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Study of Fetal Outcome in Preeclampsia and Eclampsia Syndrome

View through CrossRef
Background: Preeclampsia and eclampsia syndrome is one of the commonest medical disorders of females. The neonatal outcome is different from the normal pregnancy due to this disorder. It includes- stillbirth, low birth weight, asphyxia, and prematurity.Objective: The objective of the study was to determine the fetal outcomes in different groups of preeclampsia and eclampsiasyndrome.Materials and Methods: This cross-sectional observational study was conducted in the Department of Pathology, (BIRDEM) General Hospital, Dhaka, from July 2019 to June 2021. The study comprised 138 clinically diagnosed preeclampsia and eclampsia syndrome cases from the Department of Gynecology & Obstetric of BIRDEM and DMCH. Out of 138 cases, there were 42 cases of mild preeclampsia (mild PE), 62 were of severe preeclampsia (severe PE), and 33 were eclampsia. Relevant data and pregnancy outcome (neonatal birth weight, maturity, Apgar score, and stillbirth), were observed and recorded in a predesigned data collection sheet and statistical analyses were carried out. Ethical practice was ensured in every step of the study.Results: Among 138 cases, the mean birth weight was (2.12±0.57) kg, which was observed in the mild preeclamptic group, and the mean birth weight was (1.52±0.47) kg found in the eclamptic group. A low Apgar score (score˂7) was mainly observed in the severe PE (77.8%) followed by (84.8%) in eclampsia group. More than half of the cases were revealed stillbirth (54.4%) as the neonatal outcome in eclampsia group. A statistically significant difference was found among three groups regarding pregnancy outcome (neonatal birth weight, maturity, stillbirth, etc.).Conclusion: Majority of the fetal complications were related to the severity and duration of the preeclampsia and eclampsia syndrome. KYAMC Journal Vol. 14, No. 01, April 2023: 39-42
Title: Study of Fetal Outcome in Preeclampsia and Eclampsia Syndrome
Description:
Background: Preeclampsia and eclampsia syndrome is one of the commonest medical disorders of females.
The neonatal outcome is different from the normal pregnancy due to this disorder.
It includes- stillbirth, low birth weight, asphyxia, and prematurity.
Objective: The objective of the study was to determine the fetal outcomes in different groups of preeclampsia and eclampsiasyndrome.
Materials and Methods: This cross-sectional observational study was conducted in the Department of Pathology, (BIRDEM) General Hospital, Dhaka, from July 2019 to June 2021.
The study comprised 138 clinically diagnosed preeclampsia and eclampsia syndrome cases from the Department of Gynecology & Obstetric of BIRDEM and DMCH.
Out of 138 cases, there were 42 cases of mild preeclampsia (mild PE), 62 were of severe preeclampsia (severe PE), and 33 were eclampsia.
Relevant data and pregnancy outcome (neonatal birth weight, maturity, Apgar score, and stillbirth), were observed and recorded in a predesigned data collection sheet and statistical analyses were carried out.
Ethical practice was ensured in every step of the study.
Results: Among 138 cases, the mean birth weight was (2.
12±0.
57) kg, which was observed in the mild preeclamptic group, and the mean birth weight was (1.
52±0.
47) kg found in the eclamptic group.
A low Apgar score (score˂7) was mainly observed in the severe PE (77.
8%) followed by (84.
8%) in eclampsia group.
More than half of the cases were revealed stillbirth (54.
4%) as the neonatal outcome in eclampsia group.
A statistically significant difference was found among three groups regarding pregnancy outcome (neonatal birth weight, maturity, stillbirth, etc.
).
Conclusion: Majority of the fetal complications were related to the severity and duration of the preeclampsia and eclampsia syndrome.
KYAMC Journal Vol.
14, No.
01, April 2023: 39-42.

Related Results

Correlation of Neutrophil Lymphocyte Ration (NLR) Values with Severe Preeclampsia, HELLP Syndrome and Eclampsia
Correlation of Neutrophil Lymphocyte Ration (NLR) Values with Severe Preeclampsia, HELLP Syndrome and Eclampsia
Background:  Preeclampsia (PE) is the leading cause of maternal and fetal morbidity and mortality. The disease is characterized by hypertension (≥140/90 mmHg), proteinuria, thro...
Identification of a rational, physiologically based early biomarker and pathogenic pathway For preeclampsia
Identification of a rational, physiologically based early biomarker and pathogenic pathway For preeclampsia
<p>Preeclampsia is a hypertensive disorder of pregnancy that is diagnosed after the 20th week of gestation. It is defined by the American College of Obstetrics and Gynecology...
Profiling Coagulation for Preeclampsia and Eclampsia
Profiling Coagulation for Preeclampsia and Eclampsia
Study of Coagulation profile in preeclampsia and eclampsia comprised of 258 cases which were categorized as preeclampsia, eclampsia and control group with 86 cases in each group. A...
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Abstract Introduction Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease commonly affecting women of reproductive age. Its overlap with HELLP syndrome (Hemolysi...
Complicaciones asociadas a la preeclampsia en pacientes atendidas en el Hospital de Supe – Lima – 2021
Complicaciones asociadas a la preeclampsia en pacientes atendidas en el Hospital de Supe – Lima – 2021
Objetivo: Determinar las complicaciones asociadas a la preeclampsia en pacientes atendidas en el Hospital de Supe – Lima - 2021 Metodología: Estudio de tipo Observacional, trasvers...
Serum catestatin level in preeclampsia
Serum catestatin level in preeclampsia
Background/Aim: Preeclampsia, a significant cause of maternal morbidity and mortality, is linked to increased cardiovascular risks. Catestatin regulates cardiovascular function whi...

Back to Top